CEO Tom Polen said BD will “double down on shifting our portfolio, both organically and inorganically through tuck-in M&A, ...

Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...

This significant investment marks a pivotal moment for REEV, fueling its mission to revolutionize mobility and restore ...

Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...

The company will keep the systems on the market but is asking providers to check devices for visible cracks and return ...

The update comes about six weeks after an early alert flagged reports of 120 injuries and one death linked to reprocessing of ...

The new facility will enable production of 25 million more patient doses per year of contrast media by the end of 2027.

CEO Scott Whitaker said “an exemption was provided for most medical devices during President Trump’s first term with respect ...